Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Oneglobe Holdings Limited maintains a patent portfolio focused on the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action. This single active matter is assigned to 1 distinct examiner and is being processed within 1 distinct art unit. This represents a highly centralized prosecution profile with no current diversification across different examiners or technical units.
The busiest examiner for this portfolio is BERRY, LAYLA D, who is responsible for 1 pending office action. As this is the only pending action in the company's portfolio, this examiner's decisions will be the primary factor in the company's immediate patent outcomes. The concentration in 1 distinct art unit suggests that the current filing is situated within a specific technical specialty. Practitioners should focus on the specific examination history of this examiner to anticipate the trajectory of the pending application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERRY, LAYLA D | 1 | 66.0% | +9.0% |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18692308 | NEW COMBINATION DRUG FOR TREATING CORONAVIRUS INFECTIONS, PHARMACEUTICAL COMPOSITION AND USE THEREOF | BERRY, LAYLA D | 1693 | §112 | Non-Final OA | — | Pending | May 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOneglobe Holdings Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Layla D Berry has the most, with 1 of Oneglobe Holdings Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
